Drug intelligence / Profile preview

omega-3 fatty acids + folic acid

Development stage
Unknown
Lead developer
Reproductive Partners Medical Group
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of **omega-3 fatty acids** and **folic acid** (Vitamin B9) is an investigational therapeutic regimen developed by the **Reproductive Partners Medical Group** for the treatment of male infertility. This specific formulation was evaluated in a Phase 2 clinical trial (NCT01548625) to assess its impact on sperm quality parameters—including concentration, motility, and morphology—as well as sexual function in infertile men. Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential structural components of the sperm cell membrane; their incorporation is thought to enhance membrane fluidity and protect against oxidative damage. Folic acid serves as a critical cofactor in one-carbon metabolism, facilitating DNA synthesis and repair during spermatogenesis and helping to regulate homocysteine levels, which are often elevated in cases of subfertility.

Other names
Omega 3 and Folic AcidOmega3 and Folic AcidOmega-3 and Folic Acid
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)FFAR4 (Free fatty acid receptor 4)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on omega-3 fatty acids + folic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3 fatty acids + folic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call